Kronisk bihulebetændelse og type 2-sygdom
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Dokumenter
- Fulltext
Forlagets udgivne version, 550 KB, PDF-dokument
Diseases of the upper and lower airways are commonly described as global airway disease, which shares basic inflammatory mechanisms, and airway comobidity is frequently found. The prevalence of chronic rhinosinusitis (CRS) is 5-12%, characterised as CRS with nasal polyps (CRSwNP) or CRS without nasal polyps (CRSsNP). Inflammation in CRSwNP is often type 2, whereas CRSsNP often involves non-type 2. New monoclonal antibodies towards type-2 inflammation have been launched internationally to treat refractory severe CRSwNP, with effect on polyps, congestions and smell, as well as quality of life. This review gives a summary of the current treatment modalities.
Bidragets oversatte titel | Chronic rhinosinusitisand type 2 disease |
---|---|
Originalsprog | Dansk |
Artikelnummer | V05210446 |
Tidsskrift | Ugeskrift for Laeger |
Vol/bind | 184 |
Udgave nummer | 10 |
Antal sider | 9 |
ISSN | 0041-5782 |
Status | Udgivet - 7 mar. 2022 |
- Chronic Disease, Humans, Nasal Polyps/complications, Quality of Life, Rhinitis/complications, Sinusitis/complications
Forskningsområder
Links
- https://content.ugeskriftet.dk/sites/default/files/scientific_article_files/2022-03/v05210446_web.pdf
Forlagets udgivne version
ID: 329209300